Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Celgene Passes On Oncology Price Cap Program

Nov 03 2006

• By Jonathan M. Block

Related Content

Genentech Adds Patient Assistance Program Along With Avastin Lung Cancer Indication

Oct 12 2006

Celgene’s Revlimid Approved For Second-Line Multiple Myeloma

Jun 30 2006

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window